The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Encapsulation of Nano‐Bortezomib in Apoptotic Stem Cell‐Derived Vesicles for the Treatment of Multiple Myeloma
Abstract
Extracellular vesicles (EVs) are lipid bilayer nanovesicles released from living or apoptotic cells that can transport DNA, RNA, protein, and lipid cargo. EVs play critical roles in cell–cell communication and tissue homeostasis, and have numerous therapeutic uses including serving as carriers for nanodrug delivery. There are multiple ways to load EVs with nanodrugs, such as electroporation, extrusion, and ultrasound. However, these approaches may have limited drug‐loading rates, poor EV membrane stability, and high cost for large‐scale production. Here, it is shown that apoptotic mesenchymal stem cells (MSCs) can encapsulate exogenously added nanoparticles into apoptotic vesicles (apoVs) with a high loading efficiency. When nano‐bortezomib is incorporated into apoVs in culture‐expanded apoptotic MSCs, nano‐bortezomib‐apoVs show a synergistic combination effect of bortezomib and apoVs to ameliorate multiple myeloma (MM) in a mouse model, along with significantly reduced side effects of nano‐bortezomib. Moreover, it is shown that Rab7 regulates the nanoparticle encapsulation efficiency in apoptotic MSCs and that activation of Rab7 can increase nanoparticle‐apoV production. In this study, a previously unknown mechanism to naturally synthesize nano‐bortezomib‐apoVs to improve MM therapy is revealed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Compared to treatment through BTZ or apoVs alone, BTZ/PC-apoVs showed a stronger anti-tumor activity [184].”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [184]
In the citing paper
“BTZ/PC-apoVs significantly increased apoptosis in MM cells in vitro.”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [184]
In the citing paper
“| Multiple myeloma | BTZ/PC-apoVs | Significantly increased apoptosis in MM cells in vitro and a stronger anti-tumor activity | [184] |”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [184]
Citations
Cites
Advances in therapeutic applications of extracellular vesicles
Wiklander, O. P. B., Brennan, M. Á., Lötvall, J., Breakefield, X. O., & EL Andaloussi, S. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav8521 · Cited by 1,039
Cell death modalities: classification and pathophysiological implications
Galluzzi, L., Maiuri, M. C., Vitale, I., Zischka, H., Castedo, M., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402148 · Cited by 832
Delivery of chemotherapeutic drugs in tumour cell-derived microparticles
Tang, K., Zhang, Y., Zhang, H., Xu, P., Liu, J., Ma, J., Lv, M., Li, D., Katirai, F., Shen, G.-X., et al. (2012) · Nature Communications · doi:10.1038/ncomms2282 · Cited by 453
Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review
Rodríguez-Fuentes, D. E., Fernández-Garza, L. E., Samia-Meza, J. A., Barrera-Barrera, S. A., Caplan, A. I., & Barrera-Saldaña, H. A. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.08.006 · Cited by 376
Mesenchymal stem/stromal cells in cancer therapy
Lan, T., Luo, M., & Wei, X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01208-w · Cited by 374
Extracellular vesicles: A bright star of nanomedicine
Wu, P., Zhang, B., Ocansey, D. K. W., Xu, W., & Qian, H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120467 · Cited by 368
Wei, H., Chen, J., Wang, S., Fu, F., Zhu, X., Wu, C., Liu, Z., Zhong, G., & Lin, J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s218988 · Cited by 317
Research works printed but not linked: 71
- 10.1038/nrm.2017.125 · DOI · Paper page
- 10.3389/fimmu.2018.01486 · DOI · Paper page
- 10.1186/s13287-018-0774-8 · DOI
- 10.7150/thno.21072 · DOI
- 10.1186/s13045-018-0680-7 · DOI
- 10.1038/s41422-018-0070-2 · DOI · Paper page
- 10.1126/scitranslmed.aai8524 · DOI
- 10.1096/fj.202002777RR · DOI
- 10.1016/j.stem.2018.05.004 · DOI · Paper page
- 10.1038/s41392-022-00932-0 · DOI · Paper page
- 10.1186/s13045-021-01037-x · DOI · Paper page
- 10.1186/s13045-021-01141-y · DOI
- 10.1126/scisignal.3145re8 · DOI
- 10.1146/annurev.genet.41.110306.130244 · DOI
- 10.1038/nrneph.2017.98 · DOI
- 10.1007/s00018-011-0689-3 · DOI
- 10.1016/j.ccell.2018.05.012 · DOI
- 10.1038/s12276-019-0362-8 · DOI
- 10.1073/pnas.1811432115 · DOI
- 10.1080/20013078.2019.1608786 · DOI
- 10.1002/jev2.12240 · DOI
- 10.1021/acsnano.1c03517 · DOI · Paper page
- 10.1002/smll.202200306 · DOI · Paper page
- 10.1002/jev2.12109 · DOI · Paper page
- 10.1182/blood.2020010452 · DOI
- 10.1158/0008-5472.CAN-19-2714 · DOI
- 10.1002/ajh.26590 · DOI · Paper page
- 10.1182/blood-2014-09-568915 · DOI · Paper page
- 10.1016/S1470-2045(10)70206-0 · DOI
- 10.1016/S1470-2045(20)30452-6 · DOI · Paper page
- 10.1093/jnen/nlx043 · DOI
- 10.1007/s10439-020-02659-x · DOI
- 10.1038/bjc.1972.33 · DOI
- 10.1038/cr.2017.133 · DOI
- 10.1038/nchem.1012 · DOI
- 10.1038/s41467-018-03325-6 · DOI
- 10.1002/advs.202001374 · DOI
- 10.1021/acsami.7b14319 · DOI
- 10.7150/thno.37097 · DOI
- 10.1182/blood-2005-09-3870 · DOI
- 10.1038/sj.leu.2403823 · DOI
- 10.1016/S0025-6196(12)61350-0 · DOI
- 10.1182/blood.V81.3.767.767 · DOI
- 10.1038/s41467-021-21525-5 · DOI
- 10.3389/fimmu.2014.00538 · DOI
- 10.1242/jcs.01370 · DOI
- 10.1080/15548627.2021.1946739 · DOI
- 10.1007/s00418-022-02072-6 · DOI
- 10.1038/s41565-021-00931-2 · DOI · Paper page
- 10.1016/j.jconrel.2020.03.039 · DOI
- 10.1038/s41467-019-11718-4 · DOI · Paper page
- 10.1002/jev2.12030 · DOI
- 10.1007/s12010-018-2813-4 · DOI
- 10.1016/j.jconrel.2014.11.029 · DOI
- 10.1016/j.ijpharm.2019.118802 · DOI
- 10.1002/sctm.19-0202 · DOI
- 10.1002/stem.2575 · DOI · Paper page
- 10.1016/bs.ircmb.2015.07.009 · DOI
- 10.3390/cimb44080236 · DOI
- 10.1038/sj.onc.1204436 · DOI
- 10.1046/j.1471-4159.1997.68041679.x · DOI
- 10.1096/fasebj.14.5.729 · DOI
- 10.1038/nrc.2016.108 · DOI · Paper page
- 10.1038/s41563-021-01047-7 · DOI
- 10.1016/j.jconrel.2016.01.009 · DOI
- 10.1016/j.addr.2020.04.004 · DOI
- 10.1038/ncomms8439 · DOI
- 10.1038/nature25486 · DOI
- 10.1016/j.tcb.2018.06.007 · DOI
- Leblanc R., 2002, Cancer Res., 62, 4996
- 10.1016/j.ijbiomac.2019.09.013 · DOI
Cited by
Sorted by citations
Emerging role of exosomes in cancer therapy: progress and challenges
Li, J., Wang, J., & Chen, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02215-4 · Cited by 297
Metadata
- Authors
- Cao, Z., Li, P., Li, Y., Zhang, M., Hao, M., Li, W., Mao, X., Mo, L., Yang, C., Ding, X., Yang, Y. Y., Yuan, P., Shi, S., & Kou, X.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2023-06-06
- Volume
- 19
- Issue
- 40
- ISSN
- 1613-6810
- 1613-6829
- Cited by
- 40
- References
- 7
- Language
- en
- Funders
- National Natural Science Foundation of China (82170924, 52072418)
- Agency for Science, Technology and Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review